The role of leptin in the etiopathogenesis of anorexia nervosa and bulimia
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity - Tập 8 - Trang 130-137 - 2013
Tóm tắt
Leptin is an adipocyte-derived signal factor (167 amino acid protein) encoded by the ob gene in chromosome 7q31 that regulates eating behaviour via central neuroendocrine mechanisms. It has been shown that serum leptin levels correlate with weight and percentage body fat in normal and obese individuals, but the exact correlation between leptin and body weight in anorexic and bulimic patients has not yet been clarified. We investigated leptin levels in the serum of 58 female subjects aged 15-36 years: 10 with bulimia nervosa (BN); 12 with anorexia nervosa (AN); 12 overweight controls (not BN); 12 weight-reduced controls (not AN); and 12 normal weight controls. The aim of the study was to evaluate the possible correlations between leptin levels and the body mass index (BMI) in all five groups. Our results showed that the serum leptin levels of the bulimic patients were similar to those of the healthy controls, with a positive correlation between leptin and BMI. Although bulimic patients have very bad nutritional behaviour, their leptin levels do not appear altered. Serum leptin was significantly (p<0.001) reduced in the anorexic patients because of the dramatic decrease in adipose mass caused by the nutritional defect, as: is further supported by the significantly (p<0.001) low level of transferrinemia. Our data suggest that, although significantly reduced, serum leptin levels in fasting anorexic patients are non-linearly related to body weight (BMI).
Tài liệu tham khảo
Becker A.E., Grinspoon S.K., Klibanski A, Herzog D.B.: Eating disorders. N. Engl. J. Med., 340, 1092–1098, 1999.
Eiro M., Katoh T. et al.: Use of a proton-pump inhibitor for metabolic disturbances associated with anorexia nervosa. N. Engl. J. Med., 346, 140, 2002.
Zhang Y., Proenca R., et al.: Positional cloning of the mouse obese gene and its human homologue. Nature, 372, 425–432, 1994.
Campfield L.A., Smith F.J. et al.: Recombinant mouse OB protein; evidence for a peripheral signal linking adiposity and central neural networks. Science, 269, 546–549, 1995.
Weigle D.S., Bukowski T.R., Foster D.C., et al.: Recombinant ob protein reduces feeding and body weight in the OB/OB mouse. J. Clin. Invest., 96, 2065–2070, 1995.
Tartaglia L.A., Dembski M., Weng X., et al.: Identification and expression cloning of a leptin receptor, OB-R. Cell, 83, 1263–1271, 1995.
Shuldiner A.R., Yang R., et al.: Resistin, obesity, and insulin-resistance. The emerging role of the adipocyte as an endocrine organ. N. Engl. J. Med., 345, 1345–1346, 2001.
Musso F., Calandra C., Musso R., et al.: Evaluation of leptin protein and human thrombopoietin levels in patients with anorexia nervosa and bulimia. Hematol. J., 1 (suppl.1) abstract, 256, 76, 2001.
Musso F., Calandra C., Musso R., et al.: Relationship of human plasma leptin concentration with blood cell parameters in anorexia nervosa and bulimia patients. Hematol. J., 1 (suppl.1) abstract, 266, 76, 2001.
Ghilardi N., Skoda R.C.: The leptine receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol. Endocrinol., 11, 393–399, 1997.
Baumann H., Morella K.K., et al.: The full length leptin receptor has signalling capabilities of interleukin 6-type receptors. Proc. Natl. Acad. Sci. USA, 93, 8374–8378, 1996.
Stephens T.W., Basinski M., Bristow P.K., et al.: The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature, 377, 530–532, 1995.
Baj Y., Zhang S., et al.: Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones. J. Biol. Chem., 271, 13939–13942, 1996.
Cohen B., Novick D., Rubinstein M.: Modulation of insulin activities by leptin. Science, 274, 1185–1188, 1996.
Gainsford T., Wilson T.A., Metcalf D., et al.: Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc. Natl. Acad. Sci. USA, 93, 14564–14568, 1996.
Shimabukuro M., Koyama K., Chen G., et al.: Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc. Natl. Acad. Sci. USA, 94, 4637–4641, 1997.
Caro J., Sinha M.K., Kolacziynski L.W., Zhang P.L., Considine R.V.: Leptin: the tale of an obesity gene. Diabetes, 45, 1455–1462, 1996.
Caro J.F., Kolacziynski J.W., Nyce M.R., et al.: Decreased cerebrospinal fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet, 348, 159–161, 1996.
Maffei M., Halaas J., Ravussin E., et al.: Leptin levels in human and rodent: measurement of plasma leptin and OB RNA in obese and weight-reduced subjects. Nature Med., 1, 1155–1161, 1995.
Ahima R.S., Prabakaran D., Mantzoros C., et al.: Role of leptin in the neuroendocrine response to fasting. Nature, 382, 250–252, 1996.
Thompson F.E., Byers T.: Dietary assessment resources manual. J. Nutr. 124, 2245S–2317S, 1994.
Manson J.E., Stampfer M.J., Hennekens C.H., Willett W.C.: Body weight and longevity: a reassessment. JAMA 257, 353–358, 1987.
Calle E.E., et al.: Body mass index and mortality in a prospective cohort of U.S. adults. N. Engl. J. Med., 341, 1097–1104, 1999.
Report of a WHO expert committee: Physical status: the use and interpretation of anthropometry. WHO Tech. Rep. Ser. 854, 1–452, 1995.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM IV) Washington, DC, APA, 1994.
Garner D.M.: Professional Manual Eating Disorders Inventory, II Odessa, FL. Psychological assessment resources, 1990.
Calandra C., Gulino V. Inserra L., Giuffrida A.: The use of citalopram in an integrated approach to the treatment of eating disorders: An open study. Eat. Weight Disord., 4, 207–210, 1999.
Gendall K. A., Bulik C. M., Sullivan P.F., Joyce P.R., McIntosh V.V., Carter F.A.: Body weight in bulimia nervosa. Eat. Weight Disord., 4, 157–164, 1999.
Eckert E.D., Pommeroy C. et al.: Leptin in anorexia nervosa. J. Clin. Endocrinol. Metab., 83, 791–795, 1997.
Hebebrand J., Vanderheyden J., Devos R., et al.: Plasma concentration of obese protein in anorexia nervosa. Lancet, 346, 1624–1625, 1995.
Grinspoon S., Gullick T., Askari H., et al.: Serum leptin levels in women with anorexia nervosa. J. Clin. Endocrinol. Metab., 81, 3861–3863, 1996.
Rosenbaum M., Nicolson M., Hirsch J., et al.: Effects of gender, body composition and menopause on plasma concentrations of leptin. J. Clin. Endocrinol. Metab., 81, 3424–3427, 1996.
Argente J., Barris V., et al.: Leptin plasma levels in healthy Spanish children and adolescents, children with obesity and adolescents with anorexia and bulimia nervosa. J. Pediatr., 22, 833–838, 1997.
Sorbi S., Nacmias B., et al.: 5-HT2A promoter polymorphism in anorexia nervosa. Lancet, 351, 1785–1786, 1998.
Fulton S., Woodside B., Shizgal P. et al.: Modulation of brain reward circuitry by Leptin. Science, 287, 125–128, 2000.
Maffei M., Halaas J., Ravussin E., et al.: Leptin levels in human and rodent: measurement of plasma leptin and OB RNA in obese and weightreduced subjects. Nature Med., 1, 1155–1161, 1995.
Halaas J.L., Gajiwala K.S., Maffei M., et al.: Weight-reducing effects of the plasma protein encoded by the obese gene. Science, 269, 543–546, 1995.
Pelleymounter M.A., Cullen M.J., Baker M.B., et al.: Effects of the obese gene product on body weight regulation in the ob/ob mice. Science, 269, 540–543, 1995.
Farooqi I.S., Jebb S.A., Langmack G., et al.: Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N. Engl. J. Med., 341, 879–883, 1999.